Safety, Tolerability and Pharmacokinetics of Orally Administered BC‑3781, a Novel Antimicrobial
Latest Information Update: 24 Oct 2013
At a glance
- Drugs Lefamulin (Primary)
- Indications Community-acquired pneumonia; Respiratory tract infections; Sexually transmitted infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nabriva Therapeutics
- 24 Oct 2013 New trial record
- 10 Sep 2013 Results presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy.